Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 2003
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
Amanda E I Proudfoot, Tracy M Handel, Zoë Johnson, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 30, 2013
Chemokine receptor antagonist development
Alexandre Garin, Zoë Johnson, Aurelie Hermant, et al.
The Journal of Biological Chemistry
|
February 4, 2017
Antibody Neutralization of CXCL10 <i>in Vivo</i> Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES
Pauline Bonvin, Franck Gueneau, Vanessa Buatois, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 26, 2016
Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis
Vanessa Buatois, Laurence Chatel, Laura Cons, et al.
The Journal of Biological Chemistry
|
September 13, 2015
Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex
Marine Lacroix, François Rousseau, Florence Guilhot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 4, 2017
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
Elie Dheilly, Valéry Moine, Lucile Broyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 2004
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system
Zoë Johnson, Marie H Kosco-Vilbois, Suzanne Herren, et al.
Journal of Leukocyte Biology
|
July 30, 2008
An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo
Tracy M Handel, Zoë Johnson, David H Rodrigues, et al.
Cancer Research Communications
|
April 17, 2023
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
Zoë Johnson, Chiara Tarantelli, Elisa Civanelli, et al.
Cell Reports
|
May 19, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion
Maciej Garczyk, Gonçalo Outeiro-Pinho, Muthita Pitaktrairat, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 2003
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
Amanda E I Proudfoot, Tracy M Handel, Zoë Johnson, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 30, 2013
Chemokine receptor antagonist development
Alexandre Garin, Zoë Johnson, Aurelie Hermant, et al.
The Journal of Biological Chemistry
|
February 4, 2017
Antibody Neutralization of CXCL10 <i>in Vivo</i> Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES
Pauline Bonvin, Franck Gueneau, Vanessa Buatois, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 26, 2016
Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis
Vanessa Buatois, Laurence Chatel, Laura Cons, et al.
The Journal of Biological Chemistry
|
September 13, 2015
Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex
Marine Lacroix, François Rousseau, Florence Guilhot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 4, 2017
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
Elie Dheilly, Valéry Moine, Lucile Broyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 2004
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system
Zoë Johnson, Marie H Kosco-Vilbois, Suzanne Herren, et al.
Journal of Leukocyte Biology
|
July 30, 2008
An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo
Tracy M Handel, Zoë Johnson, David H Rodrigues, et al.
Cancer Research Communications
|
April 17, 2023
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
Zoë Johnson, Chiara Tarantelli, Elisa Civanelli, et al.
Cell Reports
|
May 19, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion
Maciej Garczyk, Gonçalo Outeiro-Pinho, Muthita Pitaktrairat, et al.
Page
of 3